Author Correction: A targetable OSGIN1-AMPK-SLC2A3 axis controls the vulnerability of ovarian cancer to ferroptosis.
Saved in:
| Title: | Author Correction: A targetable OSGIN1-AMPK-SLC2A3 axis controls the vulnerability of ovarian cancer to ferroptosis. |
|---|---|
| Authors: | Deng M; Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 100006, Beijing, China.; Laboratory for Clinical Medicine, Capital Medical University, 100006, Beijing, China., Tang F; Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 100006, Beijing, China.; Laboratory for Clinical Medicine, Capital Medical University, 100006, Beijing, China., Chang X; Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 100006, Beijing, China.; Laboratory for Clinical Medicine, Capital Medical University, 100006, Beijing, China., Zhang Y; Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 100006, Beijing, China.; Laboratory for Clinical Medicine, Capital Medical University, 100006, Beijing, China., Liu P; Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 100006, Beijing, China.; Laboratory for Clinical Medicine, Capital Medical University, 100006, Beijing, China., Ji X; Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 100006, Beijing, China.; Laboratory for Clinical Medicine, Capital Medical University, 100006, Beijing, China., Zhang Y; Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 100006, Beijing, China.; Qingdao Hospital, University of Health and Rehabilitation Sciences, 266011, Shandong, China., Yang R; Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 100006, Beijing, China.; Laboratory for Clinical Medicine, Capital Medical University, 100006, Beijing, China., Jiang J; State Key Laboratry of Medical Proteomics, National Center for Protein Sciences (Beijing), Institute of Lifeomics, 100006, Beijing, China., He J; Laboratory for Clinical Medicine, Capital Medical University, 100006, Beijing, China.; Beijing Key Laboratory for Tumor Invasion and Metastasis, Department of Biochemistry and Molecular Biology, Capital Medical University, 100006, Beijing, China., Miao J; Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 100006, Beijing, China. jinweimiao@ccmu.edu.cn.; Laboratory for Clinical Medicine, Capital Medical University, 100006, Beijing, China. jinweimiao@ccmu.edu.cn. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2025 Feb 28; Vol. 9 (1), pp. 56. Date of Electronic Publication: 2025 Feb 28. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2397-768X |
|---|---|
| DOI: | 10.1038/s41698-025-00839-3 |
